 Gateway Investment Advisers LLC lessened its holdings in shares of Charles River Laboratories Intl. Inc NYSE:CRL by 3.8 during the third quarter, according to the company in its most recent filing with the Securities Exchange Commission. The institutional investor owned 2,128 shares of the medical research companys stock after selling 85 shares during the ... 